BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10087006)

  • 1. Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis.
    Iyer SN; Gurujeyalakshmi G; Giri SN
    J Pharmacol Exp Ther; 1999 Apr; 289(1):211-8. PubMed ID: 10087006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis.
    Iyer SN; Gurujeyalakshmi G; Giri SN
    J Pharmacol Exp Ther; 1999 Oct; 291(1):367-73. PubMed ID: 10490926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung fibrosis is ameliorated by pirfenidone fed in diet after the second dose in a three-dose bleomycin-hamster model.
    Iyer SN; Margolin SB; Hyde DM; Giri SN
    Exp Lung Res; 1998; 24(1):119-32. PubMed ID: 9457473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procollagen gene expression is down-regulated by taurine and niacin at the transcriptional level in the bleomycin hamster model of lung fibrosis.
    Gurujeyalakshmi G; Iyer SN; Hollinger MA; Giri SN
    J Pharmacol Exp Ther; 1996 May; 277(2):1152-7. PubMed ID: 8627527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
    Iyer SN; Wild JS; Schiedt MJ; Hyde DM; Margolin SB; Giri SN
    J Lab Clin Med; 1995 Jun; 125(6):779-85. PubMed ID: 7539478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters.
    Wang Q; Hyde DM; Gotwals PJ; Giri SN
    Exp Lung Res; 2002 Sep; 28(6):405-17. PubMed ID: 12217209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.
    Gurujeyalakshmi G; Wang Y; Giri SN
    J Pharmacol Exp Ther; 2000 Apr; 293(1):82-90. PubMed ID: 10734156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of transforming growth factor-beta1 mRNA expression by taurine and niacin in the bleomycin hamster model of lung fibrosis.
    Gurujeyalakshmi G; Hollinger MA; Giri SN
    Am J Respir Cell Mol Biol; 1998 Mar; 18(3):334-42. PubMed ID: 9490651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis.
    Giri SN; Hyde DM; Braun RK; Gaarde W; Harper JR; Pierschbacher MD
    Biochem Pharmacol; 1997 Dec; 54(11):1205-16. PubMed ID: 9416971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation.
    Iyer SN; Hyde DM; Giri SN
    Inflammation; 2000 Oct; 24(5):477-91. PubMed ID: 10921510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of platelet-activating factor receptors in lung and alveolar macrophages in the bleomycin-hamster model of pulmonary fibrosis.
    Chen J; Ziboh V; Giri SN
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1219-27. PubMed ID: 9067307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abatement of bleomycin-induced increases in vascular permeability, inflammatory cell infiltration, and fibrotic lesions in hamster lungs by combined treatment with taurine and niacin.
    Wang Q; Hyde DM; Giri SN
    Lab Invest; 1992 Aug; 67(2):234-42. PubMed ID: 1380105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene expression of messenger RNA coding for procollagen and tumour necrosis factor-alpha in lungs undergoing bleomycin-induced pulmonary fibrosis].
    Cai H; Zheng P; Dai L
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Dec; 21(12):753-5. PubMed ID: 11480082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ hybridization analysis of rat lung alpha 1(I) and alpha 2(I) collagen gene expression in pulmonary fibrosis induced by endotracheal bleomycin injection.
    Zhang K; Gharaee-Kermani M; McGarry B; Phan SH
    Lab Invest; 1994 Feb; 70(2):192-202. PubMed ID: 7511187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity.
    Card JW; Racz WJ; Brien JF; Margolin SB; Massey TE
    Toxicol Sci; 2003 Sep; 75(1):169-80. PubMed ID: 12832656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of niacin on bleomycin-induced increases in myeloperoxidase, prolyl hydroxylase, and superoxide dismutase activities and collagen accumulation in the lungs of hamsters.
    O'Neill CA; Giri SN
    J Biochem Toxicol; 1992; 7(4):229-39. PubMed ID: 1284083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of bleomycin-induced nitric oxide production in mice by taurine and niacin.
    Gurujeyalakshmi G; Wang Y; Giri SN
    Nitric Oxide; 2000 Aug; 4(4):399-411. PubMed ID: 10944425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
    Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
    Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level.
    Gurujeyalakshmi G; Hollinger MA; Giri SN
    Am J Physiol; 1999 Feb; 276(2):L311-8. PubMed ID: 9950894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression.
    Gurujeyalakshmi G; Giri SN
    Exp Lung Res; 1995; 21(5):791-808. PubMed ID: 8556994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.